Whole blood viscosity and haematocrit are associated with internal carotid atherosclerosis in men

Coronary Artery Disease

Volumn 9, Issue 2-3, 1998, Pages 113-117

  Carallo, Claudio ^a   Pujia, Arturo ^a   Irace, Concetta ^a   De Franceschi, Maria S ^a   Motti, Corradino ^b   Gnasso, Agostino ^a,c  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

Atherosclerosis; Haematocrit blood viscosity; Rheology

Indexed keywords

FIBRINOGEN; GLUCOSE; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VISCOSITY; CAROTID ARTERY DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; INTERNAL CAROTID ARTERY; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; SHEAR RATE;

EID: 0031834488     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199802000-00008     Document Type: Article

References (47)

1. Nicolaides AN, Bowers R, Horbourne T, Kidner PH, Besterman EM. Blood viscosity, red cell flexibility, haematocrit and plasma fibrinogen in patients with angina. Lancet 1977; ii:943-945.
2. Rainer C, Kawanishi DT, Chandraratna AN, Bauersachs RM, Reid CL, Rahimtoola SH, et al. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease. Circulation 1987; 76:15-20.
3. Fuchs J, Pinhas A, Davidson E, Rotenberg Z, Agmon J, Weinberger I. Plasma viscosity, fibrinogen and hematocrit in the course of unstable angina. Eur Heart J 1990; 11:1029-1032.
4. Dormandy J, Ernst E, Matrai A, Flute PT. Hemorheologic changes following acute myocardial infarction. Am Heart J 1982; 104:1634-1637.
5. Fuchs J, Weinberger I, Teboul A, Joushua H, Agmon J. Plasma viscosity and haematocrit in the course of acute myocardial infarction. Eur Heart J 1987; 8:1195-1200.
6. Ernst E, Krauth U, Resh KL, Paulsen HP. Does blood rheology revert to normal after myocardial infarction? Br Heart J 1990; 64:248-250.
7. Lowe GDO, Drummond MM, Lorimer AR, Hotton L, Forbes CD, Prentice CRM, et al. Relation between extent of coronary artery disease and blood viscosity. BMJ 1980; 280:673-674.
8. Harrison MJG, Kendall BE, Pollock S, Marshall J. Effect of haematocrit on carotid stenosis and cerebral infarction. Lancet 1981; i:114-115.
9. Kannel WB, Gordon T, Wolf PA, McNamara P. Haemoglobin and the risk of cerebral infarction: The Framingham Study. Stroke 1972; 3:409-420.
10. Tohgi H, Yamanouchi H, Murakami M, Kameyama M. Importance of the haematocrit as a risk factor in cerebral infarction. Stroke 1978; 9:369-374.
11. Sorlie PD, Garcia-Palmieri MR, Costas R, Havlik RJ. Haematocrit and risk of coronary heart disease: The Puerto Rico Heart Health Program. Am Heart J 1981; 101:456-461.
12. Burch G, DePasquale N. Erythrocytosis and ischemic heart disease. Am Heart J 1988; 62:139-140.
13. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Withehead PJ, et al. Fibrinogen, viscosity and white blood cell count are major risk factor for ischemic heart disease. Circulation 1991; 83:836-844.
14. De Simone G, Devereux RB, Chien S, Alderman LH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990; 81:107-117.
15. Levenson J, Simon A, Cambien A, Beretti C. Cigarette smoking and hypertension: factors independently associated with blood hyperviscosity and arterial rigidity. Arteriosclerosis 1987; 7:572-577.
16. Tibblin G, Bergentz SE, Bjur I, Wilhemsen L. Haematocrit, plasma protein, plasma volume and viscosity in early hypertensives disease. Am Heart J 1966; 72:165-176.
17. Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and concentration. Am J Med 1981; 70:1195-1202.
18. Letcher RL, Chien S, Pickering TG, Laragh JH. Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 1983; 5:757-762.
19. Fowkes FG, Lowe GDO, Rumley A, Lennie SE, Smith FB, Donnan PT. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74 years. Eur Heart J 1993; 14:597-601.
20. Razavian SM, Del Pino M, Simon A, Levenson J. Increase in erythrocyte disaggregation shear stress in hypertension. Hypertension 1992; 20:247-252.
21. Wysocky M, Krotkiewski M, Braide M, Bagge U. Hemorheological disturbance, metabolic parameters and blood pressure in different types of obesity. Atherosclerosis 1991; 88:21-28.
22. Koenig W, Sund M, Ernst E, Mraz W, Hombach W, Keil U. Association between rheology and components of lipoproteins in human blood. Results from the MONICA project. Circulation 1992; 85:2197-2204.
23. Lowe GDO, Stromberg P, Forbes CD, McArdle BM, Lorimer AR, Prentice CRM. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 1982; i:472-475.
24. Carallo C, Spagnuolo V, Siclari D, Talarico R, Pujia A, Gnasso A. Rapporto tra profilo lipidico e viscosità ematica in un campione della popolazione calabrese. Minerva Cardioangiologica 1996; 44:53-57.
25. Gnasso A, Calindro MC, Carallo C, De Novara G, Ferraro M, Gorgone G, et al. Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy. Eur J Epidemiol 1997; 13:421-428.
26. Strandness DE. Non-invasive evaluation of arteriosclerosis. Comparison of methods. Arteriosclerosis 1983; 3:103-116.
27. Mercuri M, Orecchini G, Susta A, Tazza D, Ciuffetti G. Correlation between haemorheologic parameters and carotid atherosclerosis in stroke. Angiology 1989; 40:283-286.
28. Bonithon-Kopp C, Scarabin P-Y, Taquet A, Touboul P-J, Malmejac A, Guize L. Risk factor for early carotid atherosclerosis in middle aged French women. Arterioscler Thromb 1991; 11:966-972.
29. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987; 34:50-97.
30. Isogai Y, Mochzuchi K, Maeda T. Red cell filtrability in diabetes. Scand J Clin Lab Invest 1981; 41:171-173.
31. Razavian SM, Atger V, Giral P, Cambillau M, Del Pino M, Simon AC, et al. Influence of HDL subfraction on erythrocyte aggregation in hypercholeś terolemic men. Arterioscler Thromb 1994; 14:361-366.
32. Fox B, James K, Morgan B, Seed A. Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis 1982; 41:337-347.
33. Gnasso A, Carallo C, Irace C, Spagnuolo V, De Novara G, Mattioli PL, et al. Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation 1996; 94:3257-3262.
34. Friedman MH, Brinkman AM, Qin JJ, Seed WA. Relation between coronary artery geometry and the distribution of early sudanophilic lesions. Atherosclerosis 1993; 98:193-199.
35. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis: quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983; 53:502-514.
36. Fisher M, Fieman S. Geometric factors of the bifurcation in carotid atherogenesis. Stroke 1990; 21:267-271.
37. Koenig W, Ernst E. The possible role of hemorheology in atherothroḿ bogenesis. Atherosclerosis 1992; 94:93-107.
38. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985; 227:1477-1479.
39. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991; 88:1663-1671.
40. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, et al. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 1992; 90:2092-2096.
41. Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1991; 14:1-9.
42. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993; 264:H150-H156.
43. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 1993; 90:7908.
44. Caro CC, Fitzgerald JM, Schroter RC. Atheroma and arterial wall shear: observation, correlation and proposal of a shear dependent mass transfer mechanism for atherogenesis. Proc R Soc Lond (Biol) 1971; 117:109-113.
45. Matheson-Urbaitis B, Lu YS, Fronticelli C, Bucci E. Renal and systemic-hemodynamic response to isovolumic exchange transfusion with hemoglobin cross-linked with bis-(3,5-dibromosalicyl) fumarate or albumin. J Lab Clin Med 1995; 126:250-260.
46. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9269.
47. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.